Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
LUNGLIFE AI INC. DL-,0001 | 9H4 | May 31, 2024 | 0.20 | -0.97 |
LUOYANG GLASS | LUG | May 31, 2024 | 0.60 | 0.00 |
Lupaka Gold Corp | LQPA | May 31, 2024 | 0.02 | +18.92 |
Luxbright | LUR | May 31, 2024 | 0.08 | +0.24 |
Luxfer Holdings PLC Ordinary Shares | LX4A | May 31, 2024 | 10.90 | +1.87 |
Luxxfolio Holdings Inc | LUH | May 31, 2024 | 0.01 | -33.33 |
Luye Pharma Group Ltd | LUP | May 31, 2024 | 0.31 | 0.00 |
Lvmh Moet Hennessy Vuitton SE | MOHF | May 31, 2024 | 145.00 | +1.40 |
Lvmh Moet Hennessy Vuitton SE | MOH | May 31, 2024 | 733.00 | +0.11 |
Lyckegard Group AB | F55 | May 31, 2024 | 0.11 | -2.61 |
LYCOS ENERGY INC. NEW | G4P0 | May 31, 2024 | 2.28 | 0.00 |
Lyft, Inc. - Class A | LY0 | May 31, 2024 | 14.18 | -2.92 |
Lynas Rare Earths Limited | LYI | May 31, 2024 | 4.03 | 0.00 |
Lynas Rare Earths Limited American Depositary Receipts - Spo | LYIC | May 31, 2024 | 3.92 | 0.00 |
LyondellBasell Industries NV Ordinary Shares Class A (Nether | DLY | May 31, 2024 | 90.64 | +0.51 |
Lytix Biopharma | 6BG | May 31, 2024 | 0.52 | +12.36 |
L`Oreal | LORA | May 31, 2024 | 87.00 | +1.16 |
M Vest Water | 7YA | May 31, 2024 | 0.66 | 0.00 |
M&C Saatchi | IZH | May 31, 2024 | 2.34 | 0.00 |
M&G | 7MP | May 31, 2024 | 2.35 | +0.26 |
M&T Bank Corporation | MTZ | May 31, 2024 | 136.00 | +2.10 |
M.D.C. Holdings, Inc. | MDH | May 31, 2024 | 58.50 | 0.00 |
M.P. Evans Group Plc | NYP | May 31, 2024 | 9.55 | -1.04 |
M/I Homes, Inc. | 4MI | May 31, 2024 | 113.90 | +2.11 |
M1 Kliniken AG | M12 | May 31, 2024 | 21.00 | 0.00 |
M3, Inc. | 4YC | May 31, 2024 | 8.60 | +0.58 |
MAANSHAN IRON | YM9A | May 31, 2024 | 0.14 | 0.00 |
Maat Pharma S.A. | 4RD | May 31, 2024 | 7.56 | -0.53 |
Mabion S.A. | 272 | May 31, 2024 | 3.79 | -1.30 |
Mabuchi Motor Co. Ltd. | V94 | May 31, 2024 | 13.90 | +0.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.